RTICBM-74

N/A

Report date: 2025/01/26 15:39:07
NME

Base Information

Drug NameRTICBM-74
Drug Alias NameCannabinoid CB1 receptor modulator (RTI International/University of North Carolina/University at Buffalo)RTICBM-74
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor modulators
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsCocaine-Related DisordersAlcoholism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRti International
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of North Carolina, GreensboroRti InternationalUniversity At Buffalo
Inactive CompaniesN/A
Active IndicationsCocaine-Related DisordersAlcoholism
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A